Medinice S.A. (WSE: ICE)

Market Cap	51.18M
Revenue (ttm)	221.00K
Net Income (ttm)	-4.74M
Shares Out	6.46M
EPS (ttm)	-0.73
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,187
Open	8.02
Previous Close	8.00
Day's Range	7.90 - 8.30
52-Week Range	7.00 - 13.50
Beta	1.06
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Medinice

Medinice S.A. focuses on creating, developing, and commercializing medical technologies for cardiology and cardio surgery. The company provides advisory services in the field of commercialization of research and development products; and undertakes preclinical tests, clinical trials, and obtaining a certificate for sale of medical technology. Medinice S.A. was incorporated in 2012 and is headquartered in Warsaw, Poland.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 16
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: ICE

Financial Performance

In 2023, Medinice's revenue was 225,000, a decrease of -8.54% compared to the previous year's 246,000. Losses were -5.07 million, 2.98% more than in 2022.